NASDAQ:ETTX
Entasis Therapeutics Holdings Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.entasistx.comipo date
Sep 26, 2018
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial fo...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus